Gagnon Securities LLC Sells 144,275 Shares of Aspen Aerogels, Inc. $ASPN

Gagnon Securities LLC reduced its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 7.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,754,833 shares of the construction company’s stock after selling 144,275 shares during the period. Aspen Aerogels accounts for approximately 2.5% of Gagnon Securities LLC’s investment portfolio, making the stock its 16th biggest holding. Gagnon Securities LLC owned approximately 2.13% of Aspen Aerogels worth $12,214,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ASPN. Y Intercept Hong Kong Ltd bought a new stake in Aspen Aerogels in the second quarter worth approximately $484,000. SG Americas Securities LLC grew its position in shares of Aspen Aerogels by 98.6% during the 2nd quarter. SG Americas Securities LLC now owns 133,821 shares of the construction company’s stock worth $792,000 after buying an additional 66,427 shares during the period. Palogic Value Management L.P. increased its stake in shares of Aspen Aerogels by 43.5% in the 2nd quarter. Palogic Value Management L.P. now owns 610,000 shares of the construction company’s stock valued at $3,611,000 after acquiring an additional 185,000 shares in the last quarter. Federated Hermes Inc. bought a new stake in shares of Aspen Aerogels in the 2nd quarter valued at $10,459,000. Finally, Gagnon Advisors LLC acquired a new position in shares of Aspen Aerogels during the 2nd quarter valued at $3,348,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Trading Up 5.4%

NYSE:ASPN opened at $3.62 on Friday. The firm has a 50-day moving average price of $3.26 and a two-hundred day moving average price of $5.64. The firm has a market cap of $298.78 million, a price-to-earnings ratio of -0.97 and a beta of 2.94. Aspen Aerogels, Inc. has a 52 week low of $2.80 and a 52 week high of $12.71. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.33 and a current ratio of 3.94.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The business had revenue of $73.02 million during the quarter, compared to the consensus estimate of $73.42 million. Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The firm’s revenue for the quarter was down 37.8% compared to the same quarter last year. During the same quarter last year, the company earned ($0.17) EPS. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. On average, equities analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.

Analyst Ratings Changes

ASPN has been the subject of a number of research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Barclays dropped their price target on Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research note on Friday, November 7th. Finally, Canaccord Genuity Group cut their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels has a consensus rating of “Hold” and an average target price of $12.67.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 56,845 shares of the company’s stock in a transaction that occurred on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total value of $183,609.35. Following the transaction, the chief executive officer owned 494,011 shares in the company, valued at approximately $1,595,655.53. This represents a 10.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.